KLOW Blend 5mg — Vial Spec, Reconstitution Math & COA

Overview of the KLOW Blend 5mg Research Specification

The KLOW Blend combines four extensively studied research peptides—BPC-157, TB-500 (Thymosin Beta-4 fragment), GHK-Cu (Copper Tripeptide-1), and KPV (Lysine-Proline-Valine)—into a single, homogeneous lyophilized cake. In laboratory settings, multi-peptide blends are utilized to observe potential synergistic mechanisms across overlapping biochemical pathways, such as extracellular matrix remodeling, cell migration signaling, microvascular integrity, and localized cytokine regulation.

A 5mg total peptide vial specification is engineered primarily for benchtop research requiring lower total compound mass per trial run. This packaging format minimizes the risk of compound degradation over repeated sampling cycles by allowing research personnel to reconstitute smaller working quantities as needed. While custom or lower-yield formats like 5mg are frequently evaluated during early protocol design, laboratories scaling up high-throughput screens or extended longitudinal studies often transition to higher-capacity options, such as the KLOW Blend 80mg. Researchers looking for individual constituents or full catalog availability can review our complete selection via /all-peptides.

Peptide Composition and Molecular Synergy in Preclinical Models

The components of the KLOW matrix represent distinct structural and signaling classes. Preclinical literature outlines specific molecular targets for each constituent within cell culture and animal tissue models:

• BPC-157: A pentadecapeptide derived from human gastric juice sequence, studied in vitro for its upregulation of vascular endothelial growth factor (VEGF) receptor expression and focal adhesion kinase (FAK) activation, promoting cell migration and angiogenesis. • TB-500: An N-terminal acetylated fragment of Thymosin Beta-4 (Ac-SDKP motif region) that sequesters G-actin, facilitating actin polymerization, cytoskeletal reorganization, and cell motility in repair assays. • GHK-Cu: A naturally occurring copper-binding tripeptide involved in gene modulation of collagen synthesis, glycosaminoglycan production, and metalloproteinase regulation in dermal fibroblast cultures. • KPV: A C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH) that exhibits potent anti-inflammatory pathway signaling by inhibiting NF-kB nuclear translocation in epithelial cell lines.

By co-formulating these four peptides into a single matrix, investigators can analyze multi-pathway cross-talk in tissue explants and cell culture systems, evaluating whether simultaneous receptor activation yields downstream signaling effects distinct from single-agent exposure.

Reconstitution Math & Diluent Volumetric Ratios for 5mg Vials

Accurate concentration calculations are vital for reproducible pipetting and consistent molar exposure in laboratory assays. When working with a total mass of 5.0 mg (5,000 mcg) of lyophilized powder, the resulting concentration is directly governed by the volume of sterile diluent introduced into the vial.

The fundamental concentration formula is expressed as: Concentration (mg/mL) = Total Peptide Mass (mg) / Diluent Volume (mL).

• 1.0 mL Diluent Addition: Adding 1.0 mL of Bacteriostatic Water or Sterile Normal Saline to a 5mg vial yields a final concentration of 5.0 mg/mL (5.0 mcg/µL). At this concentration, a micro-pipette volume of 10 µL delivers exactly 50 mcg of total peptide blend.

• 2.0 mL Diluent Addition: Adding 2.0 mL of diluent yields a final concentration of 2.5 mg/mL (2.5 mcg/µL). In this setup, a 10 µL transfer volume delivers 25 mcg of total peptide blend.

• 3.0 mL Diluent Addition: Adding 3.0 mL of diluent yields a final concentration of 1.67 mg/mL (1.67 mcg/µL). A 10 µL volume delivers approximately 16.7 mcg of total peptide blend.

For complex calculations involving custom dilution series or molar conversion across multi-peptide ratios, scientists can utilize our online reconstitution calculator to verify laboratory math prior to liquid handling.

Step-by-Step Laboratory Reconstitution Protocol

Maintaining sterility and structural integrity during reconstitution prevents peptide aggregation and chemical cleavage. Reconstitution should always take place within a laminar flow hood or clean bench setup adhering to standard Biosafety Level (BSL) protocols.

1. Sanitization: Disinfect the rubber septum of the vial with 70% isopropyl alcohol and allow it to air-dry completely. 2. Diluent Preparation: Draw the exact required volume (e.g., 1.0 mL, 2.0 mL, or 3.0 mL) of Bacteriostatic Water (0.9% benzyl alcohol preserved) using a sterile, single-use laboratory syringe. 3. Wall-Dosing Transfer: Insert the needle through the center of the septum at a 45-degree angle. Direct the liquid stream down the inner glass wall of the vial rather than shooting it directly onto the lyophilized cake to prevent mechanical shear stress. 4. Equalizing Vacuum: Allow the natural vacuum inside the vial to draw the diluent in. If positive pressure builds, gently draw back excess air into the syringe barrel before withdrawing the needle. 5. Gentle Dissolution: Swirl the vial gently in a circular motion on the benchtop. Do NOT shake, invert vigorously, or vortex the reconstituted vial, as mechanical agitation can denature delicate peptide tertiary structures.

Inspect the solution visually under bright illumination. The final liquid should be completely clear, free of particulate matter, with a subtle blue hue characteristic of copper-bound GHK-Cu.

Aliquot Planning and Degradation Prevention

Repeated freeze-thaw cycles significantly accelerate peptide degradation via hydrolysis, oxidation, and non-specific aggregation. Once reconstituted, liquid solutions exposed to ambient air or subjected to multiple temperature fluctuations experience a rapid drop in functional purity.

To maximize shelf life and data integrity, laboratories should implement an immediate aliquotting protocol upon reconstitution. Divide the stock solution into single-use micro-centrifuge tubes (polypropylene, low-binding) corresponding to the exact volume required for planned experimental assays (e.g., 50 µL or 100 µL aliquots).

Label each aliquot tube clearly with the compound name, batch lot number, reconstituted concentration, and date. Store aliquots immediately at sub-zero temperatures (-20°C or -80°C) to lock in chemical stability until the day of execution. Discard any unused liquid from a thawed aliquot after completing the assay.

Storage Protocols: Lyophilized vs. Reconstituted Stability

Environmental controls dictate the longevity of lyophilized peptide cakes and liquid stock solutions. Lyophilized powders are structurally stable when shielded from light, moisture, and elevated temperatures.

• Unreconstituted (Lyophilized) Vials: Store at -20°C in a dry, dark environment. Sealed vials containing desiccants remain stable for up to 24 months. For short-term transit or immediate handling, room temperature storage (15°C to 25°C) is acceptable for up to 5–7 days without measurable loss of mass purity.

• Reconstituted Liquid Solutions: Store refrigerated at 2°C to 8°C if the solution will be completely consumed within 14 days. If the assay timeframe extends beyond two weeks, frozen storage at -20°C or -80°C is required. Avoid frost-free freezers, as their automated temperature cycling induces micro-thaw events that degrade peptide bonds.

Analytical Verification: Lot-Specific COA, HPLC, and Mass Spectrometry

Every batch of KLOW Blend manufactured for PX1 Research undergoes stringent analytical testing to confirm compound identity, structural integrity, purity, and safety. Every individual lot is paired with a verifiable Certificate of Analysis accessible through our public repository at /coa.

Quality control verification relies on two primary analytical techniques:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Measures chemical purity by separating components based on hydrophobic interactions. Each constituent within the KLOW matrix exhibits a distinct retention time. The integrated peak area must confirm a baseline mass purity of ≥98.0%.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight. The observed mass-to-charge (m/z) ratios must align precisely with theoretical values for BPC-157 (1419.5 Da), TB-500 fragment (889.0 Da), GHK-Cu (340.3 Da base tripeptide), and KPV (341.4 Da).

Additionally, all lots are subjected to Chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain strictly below <0.01 EU/mg, preventing confounding inflammatory artifacts during sensitive in vitro assays.

Determining Optimal Vial Capacity: 5mg vs. High-Yield Formulations

Selecting between a 5mg vial format and larger high-yield configurations depends entirely on laboratory throughput, total diluent usage, and assay protocol design.

The 5mg vial size is ideal for exploratory bench research, single-plate assays, or preliminary signal mapping where lower reconstituted volume reduces potential material waste. It minimizes long-term storage requirements and allows researchers to validate protocols before committing to larger batch volumes.

Conversely, high-density academic screening and longitudinal animal tissue studies benefit from higher total mass offerings like the KLOW Blend 80mg. Higher mass vials reduce unit-cost per milligram and ensure absolute intra-assay batch consistency across expansive experimental series. Principal investigators managing large-scale lab requirements can also coordinate custom fill volumes and volumetric batch orders through our /wholesale portal.

Comparative Analysis: KLOW Blend vs. Standalone Research Peptides

When designing preclinical trial arms, researchers often compare multi-peptide blends against individual compound treatments to differentiate synergistic activity from baseline pathway signaling.

For instance, evaluating standalone BPC-157 5mg isolate allows researchers to pinpoint specific FAK/paxillin phosphorylation pathways without confounding signals from other agents. Similarly, testing isolated TB-500 10mg isolated sequences isolates actin-monomer sequestration kinetics, while separate GHK-Cu 50mg assays isolate copper-dependent gene activation. Combining these peptides alongside KPV within the KLOW matrix enables advanced multi-factorial modeling, helping investigators measure simultaneous gene expression and structural protein synthesis across complex cell lines.